Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2
Authors
Keywords
-
Journal
Journal of Medicinal Chemistry
Volume 65, Issue 22, Pages 15443-15456
Publisher
American Chemical Society (ACS)
Online
2022-11-04
DOI
10.1021/acs.jmedchem.2c01391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
- (2022) Hui K. Gan et al. INVESTIGATIONAL NEW DRUGS
- EphA2: A promising therapeutic target in breast cancer
- (2021) Ping Zhao et al. Journal of Genetics and Genomics
- Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates
- (2021) Parima Udompholkul et al. MOLECULES
- Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads
- (2020) Gemma E. Mudd et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
- (2020) Ahmed F. Salem et al. Pharmaceuticals
- Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model
- (2020) Ahmed F. Salem et al. Cancers
- Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction
- (2018) Carmine Giorgio et al. BIOCHEMICAL PHARMACOLOGY
- Design and synthesis of small molecule agonists of EphA2 receptor
- (2018) Aaron Petty et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate
- (2018) Ahmed F. Salem et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell
- (2018) Luca Gambini et al. ACS Chemical Biology
- Targeting Eph/ephrin system in cancer therapy
- (2017) Alessio Lodola et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs
- (2016) Stephanie Heinzlmeir et al. ACS Chemical Biology
- Novel anti-EPHA2 antibody, DS-8895a for cancer treatment
- (2016) Jun Hasegawa et al. CANCER BIOLOGY & THERAPY
- EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
- (2016) Katherine R. Amato et al. CANCER RESEARCH
- Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
- (2016) Bridget A. Quinn et al. Oncotarget
- Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells
- (2015) Bainan Wu et al. CHEMISTRY & BIOLOGY
- High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists
- (2015) Bainan Wu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph–ephrin system
- (2015) Riccardo Castelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- UniPR129 is a competitive small molecule Eph-ephrin antagonist blockingin vitroangiogenesis at low micromolar concentrations
- (2014) I Hassan-Mohamed et al. BRITISH JOURNAL OF PHARMACOLOGY
- Design, Synthesis and Bioevaluation of an EphA2 Receptor-Based Targeted Delivery System
- (2014) Elisa Barile et al. ChemMedChem
- Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
- (2014) Katherine R. Amato et al. JOURNAL OF CLINICAL INVESTIGATION
- EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
- (2014) B. Miao et al. Cancer Discovery
- HTS by NMR of Combinatorial Libraries: A Fragment-Based Approach to Ligand Discovery
- (2013) Bainan Wu et al. CHEMISTRY & BIOLOGY
- Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein-Protein Antagonists
- (2013) Massimiliano Tognolini et al. ChemMedChem
- Amino Acid Conjugates of Lithocholic Acid As Antagonists of the EphA2 Receptor
- (2013) Matteo Incerti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 Receptor
- (2013) Srinivas Duggineni et al. ACS Medicinal Chemistry Letters
- The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas
- (2012) Elena Binda et al. CANCER CELL
- Copy Number Variations of EphA3 Are Associated With Multiple Types of Hematologic Malignancies
- (2012) Ming Guan et al. Clinical Lymphoma Myeloma & Leukemia
- Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
- (2012) Christina M. Annunziata et al. INVESTIGATIONAL NEW DRUGS
- Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells
- (2012) Si Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo
- (2012) Aaron Petty et al. PLoS One
- Structure−Activity Relationship Analysis of Peptides Targeting the EphA2 Receptor
- (2010) Sayantan Mitra et al. BIOCHEMISTRY
- EphA2 as a promoter of melanoma tumorigenicity
- (2010) Naira V. Margaryan et al. CANCER BIOLOGY & THERAPY
- Emerging strategies for EphA2 receptor targeting for cancer therapeutics
- (2010) Manish Tandon et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- EphA2Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
- (2010) Leonardo Faoro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration
- (2010) Eva M. Trinidad et al. Cell Adhesion & Migration
- Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients
- (2008) Wei-Jie Yuan et al. DIGESTIVE DISEASES AND SCIENCES
- Expression profile of Eph receptors and ephrin ligands in healthy human B lymphocytes and chronic lymphocytic leukemia B-cells
- (2008) Luis M. Alonso-C et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started